A multikinase inhibitor, sorafenib, inhibited proliferation and induced apoptosis in hepatocellular carcinoma cell lines, by inhibiting the MEK/ERK signaling pathway [38]. This evidence concerns the gene MAP2K7 and hepatocellular carcinoma.